Stephen Linderman
Listed on 1 Form D filing across 1+ issuer
· Executive Officer
Associated issuers
- Absco Therapeutics, Inc. CIK 2023557 · MA
Filings (1)
-
Absco Therapeutics, Inc.D · Aug 27, 2025 · MA · Biotechnology$5MView filing →